Bone Health Management for Women Diagnosed With Breast Cancer
NCT ID: NCT02484131
Last Updated: 2017-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
54 participants
INTERVENTIONAL
2015-11-30
2017-03-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient- and Physician-Based Osteoporosis Education
NCT00073190
The Effect of a Short Educational Program on Young Women's Knowledge and Beliefs About Osteoporosis
NCT00464412
Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98
NCT00369850
Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture
NCT02355340
A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
NCT00399321
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Educational materials/mail
Participants in this group will receive educational materials by mail on the first day of the follow-up period.
Educational materials/mail
Participants in this group will receive any educational materials by mail during hte follow-up period.
Educational materials/participant choice
Participants in this group will receive educational materials by participant choice on the first day of the follow-up period.
Educational materials/participant choice
Participants in this group will not receive any educational materials by participant choice during hte follow-up period.
Control
Participants in this group will not receive any educational materials during hte follow-up period. Educational materials will be sent by mail after the completion of this study.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational materials/mail
Participants in this group will receive any educational materials by mail during hte follow-up period.
Educational materials/participant choice
Participants in this group will not receive any educational materials by participant choice during hte follow-up period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Is 65-75 year old on July 1st, 2015
* Lives in British Columbia (BC), Canada
* Reads and understands the information provided in English
* Was diagnosed with breast cancer prior to July 1st, 2012
* Is not receiving surgery, radiation or chemotherapy for any cancers
* Has not had breast cancer spread beyond her breast(s) and nearby lymph nodes
* Has not had screening tests after July 1st, 2012
* Is not taking medications prescribed by doctors for osteoporosis
Exclusion Criteria
* Have terminated patient-doctor relationship with her family doctor who is indicated in our record
65 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
British Columbia Cancer Agency
OTHER
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olivia Tseng, MD
MD. MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Dawes, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
John J. Spinelli, PhD
Role: PRINCIPAL_INVESTIGATOR
British Columbia Cancer Agency
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BC Cancer Research Centre
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H15-00849
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.